Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,453.50
+15.00 (1.04%)
Jun 6, 2025, 11:00 AM CET
Genmab Market Cap
Genmab has a market cap or net worth of 88.60 billion as of June 6, 2025. Its market cap has decreased by -32.79% in one year.
Market Cap
88.60B
Enterprise Value
67.32B
Revenue
22.30B
Ranking
n/a
PE Ratio
11.35
Stock Price
1,453.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 88.60B, an increase of 2,304.81%. That is a compound annual growth rate of 13.77%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 2,116.10B |
| Coloplast | 141.54B |
| Demant | 54.28B |
| ALK-Abelló | 40.43B |
| H. Lundbeck | 35.45B |
| Zealand Pharma | 32.94B |
| Ambu A/S | 26.48B |
| Embla Medical | 14.36B |